SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-24-000861
Filing Date
2024-10-31
Accepted
2024-10-31 18:51:29
Documents
11

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13d-a.htm SC 13D/A 64728
2 PLEDGE AND SECURITY AGREEMENT, DATED AS OF MAY 9, 2024, BY AND BETWEEN TI SIE 2 exh99-5.htm EX-99.5 146690
3 ISSUER LETTER AGREEMENT, DATED AS OF MAY 9, 2024, BY AND BETWEEN AMNEAL PHARMACE exh99-6.htm EX-99.6 65192
4 image0.jpg GRAPHIC 371937
5 image1.jpg GRAPHIC 2165
6 image00006.jpg GRAPHIC 46805
7 image00007.jpg GRAPHIC 149892
8 image00012.jpg GRAPHIC 154267
9 image00013.jpg GRAPHIC 27954
10 image00014.jpg GRAPHIC 64956
11 image00015.jpg GRAPHIC 47867
  Complete submission text file 0000898432-24-000861.txt   1471198
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 241416552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Patel Chirag K. (Filed by) CIK: 0001738701 (see all company filings)

Type: SC 13D/A